tirzepatide use Long-Term Safety of Tirzepatide: What Research and Experts Reveal Can Tirzepatide Help You Lose

Researchers who extend beyond 10 weeks without a washout period report significantly diminished gains during weeks 1116 compared to weeks 58

PMCID: PMC6640854

Consider clinical review and patient engagement tools, such as prior authorization and custom care plans, to ensure members meet clinical criteria before starting on GLP-1s and members continue treatment for effective, long-term results

It is recommended that you inject the medication into your thigh, abdomen, or upper arm and to use different injection sites each time

Learning helps ground realistic expectations and promotes the early reporting of issues

Active Ingredient: Retatrutide Retatrutide is an experimental triple receptor agonistactivating GLP-1, GIP, and glucagon receptors designed to enhance weight loss and metabolic control